SQR PHARMA CONSULTING LTD

Company number 08901689 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£2,377,227

Balance sheet as at 2025-12-31

View full accounts →

What it does

The principal activity of the company during the year was related to activity of export of pharmaceutical products in foreign markets. that of a wholesaler of pharmaceutical goods.

The company's own description, from its latest filed accounts.

Overview

Company type
Private Limited Company
Incorporated
2014-02-19
Employees
3 (2025 accounts · was 4 in 2024)
Registered office
Speen House, Porter Street, London, United Kingdom, W1U 6AJ
Postcode
W1U 6AJ
Capital
200,000 GBP
Accounts category
Total Exemption Full

Accounts

Last made up to
2025-12-31
Next due by
2027-09-30
Financial year end
31 December

Confirmation statement

Last statement dated
2025-09-20
Next due by
2026-10-04
View filing history →

Nature of business (SIC)

  • 46460 Wholesale of pharmaceutical goods

Officers 3 current · 4 resigned

Appointed 2021-01-25
MR Ilya ZALTSMAN Director
Appointed 2015-11-25
Appointed 2015-05-26

View all officers and resignations →

Contact details

Website
http://www.sqrpharma.com

Previous registered addresses 3

AddressChanged on
UNIT 502 30 GREAT GUILDFORD STREET, LONDON, SE1 0HS2020-01-21
45 KING WILLIAM STREET, LONDON, EC4R 9AN2018-01-24
3 MORE LONDON RIVERSIDE, LONDON, SE1 2RE2016-06-25

Among its peers

Top 10%

by shareholders' funds, of 120 similar companies in W

Among the oldest 25% of its local peers, trading since 2014.

No.7 of the largest wholesale of pharmaceutical goods companies in London →

74 companies are registered at this postcode →

Competitors London

This company ranks 7 among wholesale of pharmaceutical goods in London.

Full league table →

The class of 2014

42%

of the 214 companies in this sector incorporated in 2014 are still active today; 54% have since been dissolved.

A fact about the year, not a forecast for this company.